Faraday Future Folds Its Robotics Unit Into a Nasdaq Listing
On September 30, a ticker on the Nasdaq will change. The listed company known as AIxC becomes FF EAI Robotics Ecosystem Inc., trading under the symbol FFR. Two days earlier,…
OpenAI Scraps a Model It Had Called Its Strongest
The superlatives were already on record. When OpenAI’s Astra family debuted this month, the company described it as the strongest model it had ever built. Now the next model in…
Anthropic Puts Top-Tier Guardrails on a Cheaper Sonnet
Anthropic’s announcement for Sonnet 5.5, posted on September 28, opened with a price list rather than a benchmark chart: $2 per million input tokens, $10 per million output tokens, and…
Anthropic and OpenAI Split Over How to Enforce Discounts
When a customer burns through the computing credits in its Anthropic contract, the phone rings quickly. The sales team calls and writes, one software executive said, to say the company…
Nvidia Tallies Anthropic’s $180 Billion of Cloud Contracts
Nvidia put a number on Anthropic’s appetite for computing power on September 28, and the number is measured in gigawatts. The chipmaker said Anthropic has signed up for 2.6 gigawatts…
Samsung Spreads $1 Billion Across KKR’s Helix Data-Center Venture
Adam Selipsky spent three years running Amazon Web Services before leaving in 2024. On September 29, the chief executive of Helix Digital Infrastructure called a new investor’s money a vote…
Anthropic’s IPO Filing Shows an $8 Billion Loss and a $518 Billion Buildout
Nearly a third of Anthropic’s IPO prospectus is given over to risk factors, and some of them read less like corporate boilerplate than like science fiction. The company warns that…
NASA Keeps Boeing’s Starliner in the Fleet, but Not for Astronauts
The announcement was tucked inside the kind of statement NASA issues when it wants a hard decision to read as routine. On September 28, the agency said it would keep…
OpenAI Leads $153 Million Round for a Startup That Revives Failed Drugs
The pharmaceutical industry discards most of what it makes. By the time a drug candidate reaches the late stages of clinical testing and fails, its owner has usually spent hundreds…
European Unions and Activists Call for an End to Palantir’s Public Contracts
Palantir Technologies has spent two years turning European governments into some of its fastest-growing customers, selling the same data-analysis software it built for U.S. intelligence agencies to police forces, health…
